Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Internal Medicine |
Vol/bind | 268 |
Udgave nummer | 3 |
Sider (fra-til) | 296-308 |
Antal sider | 13 |
ISSN | 0954-6820 |
DOI | |
Status | Udgivet - 2010 |
ID: 33248879